34.236.192.4
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

AAO

Omidenepag isopropyl non-inferior to timolol for OAG/OHT

Omidenepag isopropyl (OMDI) 0.002% was found to be non-inferior to timolol 0.5% in reducing intraocular pressure (IOP) in adults with open-angle glaucoma (OAG) or ocular hypertension (OHT), according to a presentation at AAO 2021. OMDI is currently marketed in regions in Asia under the brand name Eybelis. Reviews by regulatory...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-